Loading
Loading…
Loading…
Tender Value
₹1.3 L
EMD Value
Exempted
Closing Date
28 Aug 2026, 7:00 pm4d left
ECHS RE6
9773260
GEM/2026/B/7932559
Two Packet Bid
INDOMETHACIN 25 MG CAP,ALBENDAZOLE 400 MG TAB,AMOXYCILLIN 500 MG plus CLAVULINIC ACID 125 MG TAB,GL
Firozepur, Punjab
Item wise evaluation
BOQ
6 documents required · 6 mandatory
1 yrs
₹61,000
₹3 L
10%
OIC, 159 General Hospital, Department of Military Affairs, Indian Army, Ministry of Defence, (Niharika)
Exempted
Yes
18 Aug 2026
18 Aug 2026
28 Aug 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | INDOMETHACIN 25 MG CAP | 120 | No | FEROZEPUR | 21 | - |
| 2 | ALBENDAZOLE 400 MG TAB | 20 | No | FEROZEPUR | 21 | |
| 3 | AMOXYCILLIN 500 MG plus CLAVULINIC ACID 125 MG TAB | 4,000 | No | FEROZEPUR | 21 | |
| 4 | GLIMEPIRIDE 2MG TAB | 30,000 | No | FEROZEPUR | 21 | |
| 5 | ETORICOXCIB 90MG TAB | 1,500 | No | FEROZEPUR | 21 | |
| 6 | RECOMBINANT HUMAN ERYTHROPOIETIN ALFA 10000 IU INJ | 15 | No | FEROZEPUR | 21 | |
| 7 | TIOTROPIUM BROMIDE 9 MCG 120 METERED DOSESUNIT INHALE ROTACAP | 10 | No | FEROZEPUR | 21 | |
| 8 | TOLTERODINE 1 MG TAB | 200 | No | FEROZEPUR | 21 | |
| 9 | SYP LACTULOSE 100 ML BOTT | 300 | Bott | FEROZEPUR | 21 | |
| 10 | ATENOLOL 50 MG TAB | 1,200 | No | FEROZEPUR | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9773260.pdf
GEM_BID • 0.37 MB
item_specification_re6_2026-08-18-17-23-28_a1435815c1fca9c9701fc0a1542ba8a8.pdf
BOQ • 0.76 MB
boq_re_6_2026-08-18-17-23-28_8eaf1b6b43e6d12eec47488a7b7566ff.csv
BOQ • 0.00 MB
RFP_56363e99-61d4-48dd-b6691787057999990_niharika243.pdf
GEM_OTHER • 0.13 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].